1. Padeken, Jan, Methot, Stephen P, Gasser, Susan M. 2022. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. In Nature reviews. Molecular cell biology, 23, 623-640. doi:10.1038/s41580-022-00483-w. https://pubmed.ncbi.nlm.nih.gov/35562425/
2. Kimball, Andrew S, Davis, Frank M, denDekker, Aaron, Kunkel, Steve L, Gallagher, Katherine A. 2019. The Histone Methyltransferase Setdb2 Modulates Macrophage Phenotype and Uric Acid Production in Diabetic Wound Repair. In Immunity, 51, 258-271.e5. doi:10.1016/j.immuni.2019.06.015. https://pubmed.ncbi.nlm.nih.gov/31350176/
3. Zhang, Xinbo, Sun, Jonathan, Canfrán-Duque, Alberto, Osborne, Timothy F, Fernández-Hernando, Carlos. 2021. Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosis. In JCI insight, 6, . doi:10.1172/jci.insight.147984. https://pubmed.ncbi.nlm.nih.gov/34003795/
4. Torrano, Joachim, Al Emran, Abdullah, Hammerlindl, Heinz, Schaider, Helmut. 2019. Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming. In Clinical epigenetics, 11, 43. doi:10.1186/s13148-019-0644-y. https://pubmed.ncbi.nlm.nih.gov/30850015/
5. Ying, Liu, Fei, Xie, Jialun, Li, Jing, Li, Jing, Feng. 2020. SETDB2 promoted breast cancer stem cell maintenance by interaction with and stabilization of ΔNp63α protein. In International journal of biological sciences, 16, 2180-2191. doi:10.7150/ijbs.43611. https://pubmed.ncbi.nlm.nih.gov/32549764/
6. Ocklenburg, Sebastian, Arning, Larissa, Gerding, Wanda M, Beste, Christian, Akkad, Denis A. 2015. Left-Right Axis Differentiation and Functional Lateralization: a Haplotype in the Methyltransferase Encoding Gene SETDB2 Might Mediate Handedness in Healthy Adults. In Molecular neurobiology, 53, 6355-6361. doi:10.1007/s12035-015-9534-2. https://pubmed.ncbi.nlm.nih.gov/26572639/
7. Lin, Chiou-Hong, Wong, Stephen Hon-Kit, Kurzer, Jason H, Feng, Xuhui, Cleary, Michael L. . SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression. In Cell reports, 23, 1166-1177. doi:10.1016/j.celrep.2018.03.124. https://pubmed.ncbi.nlm.nih.gov/29694893/